Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma.

Autor: Toukam M; ADC Therapeutics, Murray Hill, NJ, USA. Marie.Toukam@adctherapeutics.com., Wuerthner J; ADC Therapeutics SA, Épalinges, Switzerland., Havenith K; ADC Therapeutics (UK) Limited, London, UK., Hamadani M; BMT and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Caimi PF; Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA., Kopotsha T; ADC Therapeutics (UK) Limited, London, UK., Cruz HG; ADC Therapeutics SA, Épalinges, Switzerland., Boni JP; ADC Therapeutics, Murray Hill, NJ, USA.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Jan; Vol. 91 (1), pp. 13-24. Date of Electronic Publication: 2022 Nov 04.

Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.

Autor: Gaio, Mario^1,2 (AUTHOR) cristina.scavone@unicampania.it, Vastarella, Maria Giovanna³ (AUTHOR) mariagiovannavastarella@hotmail.it, Sullo, Maria Giuseppa⁴ (AUTHOR) mariagiuseppa.sullo@policliniconapoli.it, Scavone, Cristina^1,2 (AUTHOR) consiglia.riccardi@unicampania.it, Riccardi, Consiglia^1,2 (AUTHOR) liberata.sportiello@unicampania.it, Campitiello, Maria Rosaria⁵ (AUTHOR) mr.campitiello@sanita.it, Sportiello, Liberata^1,2 (AUTHOR) concetta.rafaniello@unicampania.it, Rafaniello, Concetta^1,2 (AUTHOR)

Publikováno v: Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p904. 15p.

Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding.

Autor: Davé E; a UCB Celltech , Slough , UK., Adams R; a UCB Celltech , Slough , UK., Zaccheo O; a UCB Celltech , Slough , UK., Carrington B; a UCB Celltech , Slough , UK., Compson JE; a UCB Celltech , Slough , UK., Dugdale S; a UCB Celltech , Slough , UK., Airey M, Malcolm S; a UCB Celltech , Slough , UK., Hailu H; a UCB Celltech , Slough , UK., Wild G; a UCB Celltech , Slough , UK., Turner A; a UCB Celltech , Slough , UK., Heads J; a UCB Celltech , Slough , UK., Sarkar K; a UCB Celltech , Slough , UK., Ventom A; a UCB Celltech , Slough , UK., Marshall D; a UCB Celltech , Slough , UK., Jairaj M; a UCB Celltech , Slough , UK., Kopotsha T; a UCB Celltech , Slough , UK., Christodoulou L; a UCB Celltech , Slough , UK., Zamacona M; a UCB Celltech , Slough , UK., Lawson AD; a UCB Celltech , Slough , UK., Heywood S; a UCB Celltech , Slough , UK., Humphreys DP; a UCB Celltech , Slough , UK.

Publikováno v: MAbs [MAbs] 2016 Oct; Vol. 8 (7), pp. 1319-1335. Date of Electronic Publication: 2016 Aug 17.

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.

Autor: Plasencia-Rodríguez, Chamaida, Martínez-Feito, Ana, Novella-Navarro, Marta, Pérez De Diego, Rebeca, Bonilla, Gema, Elin Gehin, Johanna, Villalba-Yllán, Alejandro, Nuño, Laura, Pascual-Salcedo, Dora, Nozal, Pilar, Díaz Almirón, Mariana, Balsa, Alejandro

Publikováno v: Frontiers in Medicine; 2024, p1-8, 8p

Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.

Autor: Sahuquillo-Torralba A; Department of Dermatology, Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain., Mansilla-Polo M; Department of Dermatology, Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain., Pujol-Marco C; Department of Dermatology, Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain., Llamas-Velasco M; Department of Dermatology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain., Rull EV; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Ruiz Villaverde R; Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain., Ferran M; Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions, Barcelona, Spain., Pitarch G; Department of Dermatology, Hospital General Universitario, Castellón, Spain., Lopez A; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Beltran E; Department of Rheumatology, Hospital del Mar, Barcelona, Spain., Urruticoechea-Arana A; Department of Rheumatology, Hospital de Can Misses, Ibiza, Spain., Riera-Monroig J; Department of Dermatology, Hospital Clinic de Barcelona, Barcelona, Spain., Alsina M; Department of Dermatology, Hospital Clinic de Barcelona, Barcelona, Spain., Vidal D; Department of Dermatology, Hospital de Igualada, Barcelona, Spain., Belinchón Romero I; Department of Dermatology, Hospital General Universitario Dr. Balmis-ISABIAL, Universidad Miguel Hernández, Alicante, Spain., Notario J; Department of Dermatology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Carrascosa JM; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain., Gonzalez-Delgado V; Department of Dermatology, Hospital Clínico Universitario, Valencia, Spain., Mollet J; Department of Dermatology, Hospital Vall d'Hebron, Barcelona, Spain., Ribera M; Department of Dermatology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain., Gallardo F; Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions, Barcelona, Spain.

Publikováno v: International journal of dermatology [Int J Dermatol] 2024 Dec; Vol. 63 (12), pp. 1720-1727. Date of Electronic Publication: 2024 May 12.